USPTO trademark

ROMVIMZA

RegisteredUSPTOWord and designClass 5

"ROMVIMZA" is a word and design mark owned by Deciphera Pharmaceuticals, LLC, filed at the USPTO on October 24, 2024. It is registered and covers class 5 (Pharmaceuticals).

View Deciphera Pharmaceuticals, LLC portfolioGet this data via the API
Official USPTO record
ROMVIMZA trademark as filed
As filed with the USPTO
Status
Registered
Since September 9, 2025
Filed
October 24, 2024
Registered
September 9, 2025
Expires
Not recorded
Application no.
98817650
Registration no.
7934470
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
1 class
Ownership

Who owns ROMVIMZA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Deciphera Pharmaceuticals, LLC

Waltham, United States

27 trademarks in the portfolioView company

Representative

Karen Won

Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.

Goods and services

What the mark covers

The products and services ROMVIMZA is filed for, grouped by Nice class.

  • Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD); Therapeutic agents, namely, kinase inhibitors

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Approved for pub - principal register
  7. Examiner's amendment entered
  8. Notification of examiners amendment e-mailed
  9. Examiners amendment e-mailed
  10. Examiners amendment -written

10 earlier steps on the official record.

FAQ

About ROMVIMZA

Who owns the trademark "ROMVIMZA"?

The USPTO trademark "ROMVIMZA" (application 98817650) is owned by Deciphera Pharmaceuticals, LLC.

What is the status of "ROMVIMZA"?

Its status at the USPTO is: registered.

When was "ROMVIMZA" registered?

It was registered on September 9, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ROMVIMZA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2a00-67fd-76e2-a377-cbeceff099fe
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2a00-67fd-76e2-a377-cbeceff099fe",
  "object": "trademark",
  "mark_text": "ROMVIMZA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98817650",
  "filing_date": "2024-10-24",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Deciphera Pharmaceuticals, LLC",
      "entity_id": "ent_019eb70e-1560-772f-84a3-dc8bf6c5ea81"
    }
  ]
}